Low use of placebo in comparative drug rcts in migraine. Are clinical investigators unaware of basic methodological issues?

Ítems similars

• Is recruitment more difficult with a placebo arm in RCTs? : Methodological issues will have affected results
  per: Forbes, Lindsay, et al.
  Publicat: (1999)
• Are the current IHS guidelines for migraine drug trials being followed?
  per: Hougaard, Anders, et al.
  Publicat: (2010)
• The importance of co-morbidity and environmental risk factors for the development of migraine
  per: Le, H, et al.
  Publicat: (2013)
• Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
  per: Hansen, Jakob Møller, et al.
  Publicat: (2019)
• Understanding clinical trials in migraine
  per: Tfelt-Hansen, P.
  Publicat: (2006)